Abacavir and Hepatotoxicity aggravated - a phase IV clinical study of FDA data

Summary:

Hepatotoxicity aggravated is reported as a side effect among people who take Abacavir (abacavir sulfate), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Kaletra, and have Psychotic disorder.

The phase IV clinical study analyzes which people have Hepatotoxicity aggravated when taking Abacavir. It is created by eHealthMe based on reports of 8,281 people who have side effects when taking Abacavir from the FDA, and is updated regularly.

What is Abacavir?

Abacavir has active ingredients of abacavir sulfate. It is often used in hiv infection. eHealthMe is studying from 8,306 Abacavir users. Check the latest studies of Abacavir.

What is Hepatotoxicity aggravated?

Hepatotoxicity aggravated (serious chemical-driven liver damage) is found to be associated with 925 drugs and 413 conditions by eHealthMe. Check the latest studies of Hepatotoxicity aggravated.

On Jul, 31, 2026

8,281 people reported to have side effects when taking Abacavir.
Among them, 170 people (2.05%) have Hepatotoxicity aggravated.

Could Abacavir cause Hepatotoxicity aggravated?

Among these 170 people:

How long have people been on Abacavir when they have Hepatotoxicity aggravated? *

Click here to view more results

What is the gender of people who have Hepatotoxicity aggravated when taking Abacavir? *

Click here to view

What is the age of people who have Hepatotoxicity aggravated when taking Abacavir? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Abacavir and have Hepatotoxicity aggravated?

- Check whether Hepatotoxicity aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Abacavir:

Abacavir (8,306 reports)

Hepatotoxicity aggravated treatments and more:

Hepatotoxicity aggravated (47 reports)

How severe was Hepatotoxicity aggravated and when was it recovered:

Hepatotoxicity aggravated in Abacavir

Expand to all the drugs that have ingredients of abacavir sulfate:

Hepatotoxicity aggravated and drugs with ingredients of abacavir sulfate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Abacavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatotoxicity aggravated:

Hepatotoxicity aggravated (925 drugs)

Browse all the conditions that are associated with Hepatotoxicity aggravated:

Hepatotoxicity aggravated (413 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on abacavir sulfate (the active ingredients of Abacavir) and Abacavir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.